scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1021178108 |
P356 | DOI | 10.1038/APS.2009.83 |
P932 | PMC publication ID | 4006662 |
P698 | PubMed publication ID | 19575001 |
P5875 | ResearchGate publication ID | 26338508 |
P50 | author | Jing Zhang | Q60322603 |
P2093 | author name string | Jin-Fu Xu | |
Peng Xu | |||
Hong-Ni Jiang | |||
Jie-Ming Qu | |||
Hui-Jun Zhang | |||
P2860 | cites work | Systemic Fungal Infections Caused by Aspergillus Species: Epidemiology, Infection Process and Virulence Determinants | Q22305789 |
Aspergillus fumigatus: principles of pathogenesis and host defense | Q24681995 | ||
Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome | Q24811601 | ||
Aspergillus fumigatus and aspergillosis | Q29617908 | ||
Oxidative stress and pulmonary inflammation: pharmacological intervention with antioxidants. | Q33754922 | ||
Ginkgo biloba extract (EGb 761) attenuates lung injury induced by intestinal ischemia/reperfusion in rats: roles of oxidative stress and nitric oxide | Q33787874 | ||
The pathobiology of Aspergillus fumigatus | Q34341968 | ||
A dual effect of N-acetylcysteine on acute ethanol-induced liver damage in mice | Q34488549 | ||
Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients | Q34630182 | ||
Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease | Q35745445 | ||
Current approaches to diagnosis and treatment of invasive aspergillosis | Q36357893 | ||
Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus | Q36482511 | ||
Comparative efficacies of four amphotericin B formulations--Fungizone, amphotec (Amphocil), AmBisome, and Abelcet--against systemic murine aspergillosis | Q36489697 | ||
Differences in pathogenicity and clinical syndromes due to Aspergillus fumigatus and Aspergillus flavus | Q37226618 | ||
Efficacy of amphotericin B or itraconazole in a murine model of central nervous system Aspergillus infection | Q39740590 | ||
Characterisation of the phagocytic uptake of Aspergillus fumigatus conidia by macrophages | Q40016783 | ||
TLRs govern neutrophil activity in aspergillosis | Q40483206 | ||
Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis | Q40734608 | ||
N-acetylcysteine: pharmacological considerations and experimental and clinical applications. | Q40916404 | ||
Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients | Q41998776 | ||
Reassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyte | Q43187504 | ||
Differences in normal values for murine white blood cell counts and other hematological parameters based on sampling site | Q43802798 | ||
Effects of N-acetylcysteine and ambroxol on the production of IL-12 and IL-10 in human alveolar macrophages | Q44209179 | ||
Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis | Q44548714 | ||
Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin | Q44583938 | ||
The effect of antioxidant treatment in pneumonia of granulocytopenic rats | Q45213168 | ||
Effect of dose of hypertonic saline on its potential to prevent lung tissue damage in a mouse model of hemorrhagic shock. | Q45941435 | ||
Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis | Q46729762 | ||
A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic. | Q54424829 | ||
Cytokine profiling of pulmonary aspergillosis. | Q54588391 | ||
Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rate model of pulmonary aspergillosis. | Q54626435 | ||
Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice | Q59413542 | ||
[Pathogenicity of various species of Candida in mice immunodepressed with cyclophosphamide] | Q70612913 | ||
Effect of amphotericin B lipid formulation on immune response in aspergillosis | Q73098476 | ||
Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis | Q79829012 | ||
Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
Pulmonary nocardiosis with multiple cavitary nodules in a HIV-negative immunocompromised patient | Q80891404 | ||
Role of collectins in innate immunity against aspergillosis | Q81094937 | ||
Th1/Th2 in aspergillosis | Q92928837 | ||
Aspergillosis in the ICU - The new 21st century problem? | Q92929057 | ||
P433 | issue | 7 | |
P921 | main subject | aspergillosis | Q259626 |
pulmonary injury | Q7259546 | ||
invasive pulmonary aspergillosis | Q54946623 | ||
P304 | page(s) | 980-986 | |
P577 | publication date | 2009-07-01 | |
P1433 | published in | Acta Pharmacologica Sinica | Q15749885 |
P1476 | title | NAC is associated with additional alleviation of lung injury induced by invasive pulmonary aspergillosis in a neutropenic model | |
P478 | volume | 30 |
Q34367333 | Antifungal and antihepatotoxic effects of sepia ink extract against oxidative stress as a risk factor of invasive pulmonary aspergillosis in neutropenic mice |
Q40138687 | Effects of intranasally dosed posaconazole on fungal load and biomarkers in Aspergillus fumigatus infected immunocompromised mice. |
Q34336393 | Erythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in Mice |
Q40688557 | In vitro susceptibility of Scedosporium isolates to N-acetyl-L-cysteine alone and in combination with conventional antifungal agents |
Search more.